Evaluation of a Probiotic On Anxiety and Stress in Healthy Adults Sensible to Daily Stress

Not Applicable

Completed

• Conditions: Anxiety; Stress
• Interventions: Dietary Supplement: Placebo during 30 days; Dietary Supplement: PROBIOSTICK® during 30 days

• Registration Number: NCT00807157
• Lead Sponsor: Institut Rosell Lallemand

Brief Summary

The purpose of the the study is to determine if PROBIOSTICK® decrease stress and anxiety of people sensible to daily stress.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-12
• Study First Submitted: 2008-12-08
• Study First Submitted QC: 2008-12-10
• Study First Posted: 2008-12-11
• Status Verified: 2009-04
• Primary Completion: 2009-04
• Study Completion: 2009-04
• Last Update Submitted: 2009-04-23
• Last Update Posted: 2009-04-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

• Caucasian healthy men or women
• Age 30-60 years
• Hospital anxiety and depression score equal or below 12 and above 4
• Standard safety biology

Exclusion Criteria

• HAD A results above 12 and below 4
• HAD D results above 12
• Neurologic or psychiatric pathology
• Consumption of psychotropic
• High level of caffeine consumption
• Any important chronic pathology
• Drugs wich impairs concentration, anxiety and stress

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
2	Placebo during 30 days	Every morning subjects will consume a stick of placebo during 30 days
1	PROBIOSTICK® during 30 days	Every morning subjects will consume a stick of PROBIOSTICK® during 30 days

Primary Outcome Measures

Name	Time	Method
SCL 90 questionnaire	day 0 and day 30

Secondary Outcome Measures

Name	Time	Method
Stress perçu, coping de vitaliano, hospital anxiety and depression questionnaires and urinary cortisol measurement	day-14 ; day 0 and day 30

Trial Locations

Locations (1)

Biofortis; 🇫🇷 Nantes, France